نتائج البحث - Jean‐Paul R. Herrman

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the <scp>TIMI</scp>‐38 Coronary Stent Registry

    Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the <scp>TIMI</scp>‐38 Coronary... حسب Marc P. Bonaca, Sabina A. Murphy, Debra L. Miller, Jean‐Paul R. Herrman, Shmuel Gottlieb, Matyàs Keltai, Alberto Menozzi, José Carlos Nicolau, Petr Widimský, Elliott M. Antman, Stephen D. Wiviott

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A Comparison of Hirudin with Heparin in the Prevention of Restenosis after Coronary Angioplasty

    A Comparison of Hirudin with Heparin in the Prevention of Restenosis after Coronary Angioplasty حسب Patrick W. Serruys, Jean‐Paul R. Herrman, Rüdiger Simon, Wolfgang Rutsch, Christoph Bode, GertJan Laarman, Rene van Dijk, Arjan A. van den Bos, Victor A. Umans, Keith A.A. Fox, Philip Close, Jaap W. Deckers

    منشور في 1995
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

    Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction حسب Stephen J. Nicholls, Yu Kataoka, Steven E. Nissen, Francesco Prati, Stephan Windecker, Rishi Puri, Thomas Hucko, Daniel Aradi, Jean‐Paul R. Herrman, Renicus S. Hermanides, Bei Wang, Huei Wang, Julie Butters, Giuseppe Di Giovanni, Stephen Jones, Gianluca Pompili, Peter J. Psaltis

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCI

    A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCI حسب Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer, Renicus S. Hermanides, Arnoud W.J. van ‘t Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M. Tjon Joe Gin, Folkert W. Asselbergs, Arend Mosterd, Jean‐Paul R. Herrman, Willem J.M. Dewilde, Paul W.A. Janssen, Johannes C. Kelder, Maarten J. Postma, Anthonius de Boer, Cornelis Boersma, Vera H.M. Deneer, Jurriën M. ten Berg

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: